Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anders Lindberg

Showing results (51-60 of 69) with videos related to

Pageof 7
Sort By:
Hormone Research|January 18, 2007
Age at growth hormone therapy start and first-year responsiveness to growth hormone are major determinants of height outcome in idiopathic short statureMichael B Ranke, Anders Lindberg, David A Price, et al.
Hormone Research in Paediatrics|July 27, 2012
Accurate long-term prediction of height during the first four years of growth hormone treatment in prepubertal children with growth hormone deficiency or Turner SyndromeMichael B Ranke, Anders Lindberg, Mathias Brosz, et al.
The Journal of Clinical Endocrinology and Metabolism|January 10, 2003
Prediction of response to growth hormone treatment in short children born small for gestational age: analysis of data from KIGS (Pharmacia International Growth Database)Michael B Ranke, Anders Lindberg, Christopher T Cowell, et al.
Hormone Research|September 5, 2003
The KIGS experience with the addition of gonadotropin-releasing hormone agonists to growth hormone (GH) treatment of children with idiopathic GH deficiencyEdward O Reiter, Anders Lindberg, Michael B Ranke, et al.
The Journal of Clinical Endocrinology and Metabolism|June 2, 2020
Near-Adult Height After Growth Hormone Treatment in Children Born Prematurely-Data From KIGSMargaret C S Boguszewski, Martin Carlsson, Anders Lindberg, et al.
Hormone Research|March 12, 2005
Insulin-like growth factors as diagnostic tools in growth hormone deficiency during childhood and adolescence: the KIGS experienceMichael B Ranke, Roland Schweizer, Anders Lindberg, et al.
Hormone Research in Paediatrics|March 1, 2013
Towards optimal treatment with growth hormone in short children and adolescents: evidence and thesesMichael B Ranke, Anders Lindberg, Primus E Mullis, et al.
Journal of Pediatric Endocrinology & Metabolism : JPEM|September 14, 2017
Individualised growth response optimisation (iGRO) tool: an accessible and easy-to-use growth prediction system to enable treatment optimisation for children treated with growth hormoneJane Loftus, Anders Lindberg, Ferah Aydin, et al.
Hormone Research|January 4, 2005
Bone age progression during the first year of growth hormone therapy in pre-pubertal children with idiopathic growth hormone deficiency, Turner syndrome or idiopathic short stature, and in short children born small for gestational age: analysis of data from KIGS (Pfizer International Growth Database)Feyza Darendeliler, Michael B Ranke, Bert Bakker, et al.
Hormone Research in Paediatrics|June 6, 2015
Short Children with CHARGE Syndrome: Do They Benefit from Growth Hormone Therapy?Helmuth G Dörr, Margaret Boguszewski, Jovanna Dahlgren, et al.
Pageof 7

Showing results (51-60 of 69) with videos related to

Sort By:
Pageof 7
Hormone Research|January 18, 2007
Age at growth hormone therapy start and first-year responsiveness to growth hormone are major determinants of height outcome in idiopathic short statureMichael B Ranke, Anders Lindberg, David A Price, et al.
Hormone Research in Paediatrics|July 27, 2012
Accurate long-term prediction of height during the first four years of growth hormone treatment in prepubertal children with growth hormone deficiency or Turner SyndromeMichael B Ranke, Anders Lindberg, Mathias Brosz, et al.
The Journal of Clinical Endocrinology and Metabolism|January 10, 2003
Prediction of response to growth hormone treatment in short children born small for gestational age: analysis of data from KIGS (Pharmacia International Growth Database)Michael B Ranke, Anders Lindberg, Christopher T Cowell, et al.
Hormone Research|September 5, 2003
The KIGS experience with the addition of gonadotropin-releasing hormone agonists to growth hormone (GH) treatment of children with idiopathic GH deficiencyEdward O Reiter, Anders Lindberg, Michael B Ranke, et al.
The Journal of Clinical Endocrinology and Metabolism|June 2, 2020
Near-Adult Height After Growth Hormone Treatment in Children Born Prematurely-Data From KIGSMargaret C S Boguszewski, Martin Carlsson, Anders Lindberg, et al.
Hormone Research|March 12, 2005
Insulin-like growth factors as diagnostic tools in growth hormone deficiency during childhood and adolescence: the KIGS experienceMichael B Ranke, Roland Schweizer, Anders Lindberg, et al.
Hormone Research in Paediatrics|March 1, 2013
Towards optimal treatment with growth hormone in short children and adolescents: evidence and thesesMichael B Ranke, Anders Lindberg, Primus E Mullis, et al.
Journal of Pediatric Endocrinology & Metabolism : JPEM|September 14, 2017
Individualised growth response optimisation (iGRO) tool: an accessible and easy-to-use growth prediction system to enable treatment optimisation for children treated with growth hormoneJane Loftus, Anders Lindberg, Ferah Aydin, et al.
Hormone Research|January 4, 2005
Bone age progression during the first year of growth hormone therapy in pre-pubertal children with idiopathic growth hormone deficiency, Turner syndrome or idiopathic short stature, and in short children born small for gestational age: analysis of data from KIGS (Pfizer International Growth Database)Feyza Darendeliler, Michael B Ranke, Bert Bakker, et al.
Hormone Research in Paediatrics|June 6, 2015
Short Children with CHARGE Syndrome: Do They Benefit from Growth Hormone Therapy?Helmuth G Dörr, Margaret Boguszewski, Jovanna Dahlgren, et al.
Pageof 7